0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Krypton Laser Membranotomy for Premacular Hemorrhage

      ,

      Ophthalmologica

      S. Karger AG

      Krypton laser, Laser membranotomy, Premacular hemorrhage

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: To evaluate the safety and effectiveness of krypton laser membranotomy. Methods: Eleven patients (12 eyes) with premacular hemorrhage were enrolled from April 1998 to November 2002. The causes of premacular hemorrhage were proliferative diabetic retinopathy (7 patients, 8 eyes), Valsalva retinopathy (3 patients) and leukemia (1 eye). Krypton laser was used to create a membranotomy on the sloping edge of the premacular hemorrhage. Five eyes with proliferative diabetic retinopathy were treated with inferior panretinal photocoagulation and laser membranotomy simultaneously. After intravitreal dispersion of premacular blood, fundus examinations were performed in all eyes and fluorescein angiography in 5 patients to evaluate the retinal damage. Results: Vision was improved within 2 weeks after surgery in all eyes with premacular hemorrhage, which received krypton laser membranotomy. No retinal damage was seen at the site of membranotomy. No eye needed vitrectomy postoperatively during the follow-up (mean, 17 months). Conclusion: Krypton laser membranotomy appears to be a safe and simple alternative procedure for treating selected cases of premacular hemorrhage. Further trials are necessary to evaluate its benefit.

          Related collections

          Most cited references 3

          • Record: found
          • Abstract: not found
          • Article: not found

          Vitrectomy in the management of diabetic eye disease

           Ho,  Tony Ho,  William Smiddy (1992)
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Zur Therapie präretinaler Makulablutungen

             P Kroll,  H Busse,  P Kroll (1986)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              ARGON LASER TREATMENT FOR PREMACULAR HEMORRHAGE

                Bookmark

                Author and article information

                Journal
                OPH
                Ophthalmologica
                10.1159/issn.0030-3755
                Ophthalmologica
                S. Karger AG
                0030-3755
                1423-0267
                2004
                December 2004
                19 November 2004
                : 218
                : 6
                : 368-371
                Affiliations
                Department of Ophthalmology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan
                Article
                80938 Ophthalmologica 2004;218:368–371
                10.1159/000080938
                15564753
                © 2004 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                Page count
                Figures: 1, Tables: 1, References: 17, Pages: 4
                Categories
                Original Paper

                Comments

                Comment on this article